Vanguard Group Portfolio holdings
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$3.46B |
| 2 |
Truist Financial
TFC
|
+$2.5B |
| 3 |
Alibaba
BABA
|
+$2.04B |
| 4 |
Uber
UBER
|
+$1.04B |
| 5 |
ServiceNow
NOW
|
+$937M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$5.45B |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$2.42B |
| 3 |
VIAB
Viacom Inc. Class B
VIAB
|
+$967M |
| 4 |
Global Payments
GPN
|
+$641M |
| 5 |
GWR
Genesee & Wyoming Inc.
GWR
|
+$574M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.84% |
| 2 | Financials | 15% |
| 3 | Healthcare | 13.05% |
| 4 | Consumer Discretionary | 9.93% |
| 5 | Industrials | 9.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3351
The ONE Group
STKS
$54.3M
| $2.81M | ﹤0.01% |
770,817
+100
| +0% | +$311 |
|
3352
Intellicheck
IDN
$76.8M
| $2.8M | ﹤0.01% |
374,273
+11,363
| +3% | +$70.5K |
|
3353
Star Group
SGU
$419M
| $2.79M | ﹤0.01% |
294,989
+4,969
| +2% | +$46.6K |
|
3354
Stratasys
SSYS
$760M
| $2.78M | ﹤0.01% |
137,635
-10,649
| -7% | -$212K |
|
|
AXAS
3355
DELISTED
Abraxas Petroleum Corp
AXAS
| $2.77M | ﹤0.01% |
395,152
-2,950
| -0.7% | -$19K |
|
3356
Celcuity
CELC
$4.55B
| $2.77M | ﹤0.01% |
260,801
-1,241
| -0.5% | -$16.3K |
|
|
NESR
3357
National Energy Services Reunited Corp
NESR
$2.91B
| $2.69M | ﹤0.01% |
295,448
-948,758
| -76% | -$7.33M |
|
3358
UroGen Pharma
URGN
$2.22B
| $2.69M | ﹤0.01% |
80,589
-1,419
| -2% | -$38.7K |
|
3359
Kingstone Companies
KINS
$301M
| $2.69M | ﹤0.01% |
346,601
+34,882
| +11% | +$277K |
|
3360
Aclaris Therapeutics
ACRS
$851M
| $2.67M | ﹤0.01% |
1,411,933
+36,090
| +3% | +$59.8K |
|
|
FRG
3361
DELISTED
Franchise Group, Inc.
FRG
| $2.67M | ﹤0.01% |
+115,008
| New | +$1.96M |
|
|
IEC
3362
DELISTED
IEC Electronics Corp.
IEC
| $2.67M | ﹤0.01% |
293,087
+14,438
| +5% | +$109K |
|
|
ASNA
3363
DELISTED
Ascena Retail Group, Inc.
ASNA
| $2.66M | ﹤0.01% |
347,148
-16,569
| -5% | -$136K |
|
3364
Luxfer Holdings
LXFR
$457M
| $2.66M | ﹤0.01% |
143,530
+41,316
| +40% | +$711K |
|
|
NEOS
3365
DELISTED
Neos Therapeutics, Inc
NEOS
| $2.66M | ﹤0.01% |
1,759,561
| – | – |
|
3366
Comstock Resources
CRK
$3.88B
| $2.65M | ﹤0.01% |
321,971
+1,912
| +0.6% | +$13.4K |
|
|
GOL
3367
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
| $2.64M | ﹤0.01% |
146,010
| – | – |
|
3368
Townsquare Media
TSQ
$114M
| $2.63M | ﹤0.01% |
264,198
+12,417
| +5% | +$96.7K |
|
|
ZVO
3369
DELISTED
Zovio Inc. Common Stock
ZVO
| $2.63M | ﹤0.01% |
1,274,613
| – | – |
|
3370
Wrap Technologies
WRAP
$109M
| $2.62M | ﹤0.01% |
410,515
+9,229
| +2% | +$42.3K |
|
|
BXRX
3371
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
| $2.62M | ﹤0.01% |
+271
| New | +$2.31M |
|
|
MJCO
3372
DELISTED
Majesco
MJCO
| $2.62M | ﹤0.01% |
317,930
-1,638
| -0.5% | -$13.8K |
|
|
CDTX
3373
DELISTED
Cidara Therapeutics
CDTX
| $2.61M | ﹤0.01% |
33,954
| – | – |
|
|
DMTK
3374
DELISTED
DermTech, Inc. Common Stock
DMTK
| $2.6M | ﹤0.01% |
+209,393
| New | +$1.84M |
|
3375
Citizens Community Bancorp
CZWI
$209M
| $2.57M | ﹤0.01% |
209,980
+121,196
| +137% | +$1.41M |
|
Similar funds
Vanguard Group's Q4 2019 Portfolio in Review
As of Q4 2019, Vanguard Group held 4,214 positions worth $2.93T, up 8.7% from $2.7T the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 3.5%. Vanguard Group opened 61 new positions and exited 87, leaving the 4,214-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
- Vanguard Group's largest Q4 2019 buy was Broadmark Realty Capital Inc. Common Stock: 8,851,056 shares worth $113M.
- Vanguard Group added most to Bristol-Myers Squibb in Q4 2019, an estimated $3.46B increase.
- Vanguard Group's biggest Q4 2019 reduction was Global Payments, cutting an estimated $641M.
- Vanguard Group fully exited Celgene Corp in Q4 2019, selling an estimated $5.45B.
- Vanguard Group's ten largest holdings make up 16% of its $2.93T portfolio in Q4 2019.
- Vanguard Group opened 61 new positions and closed 87 in Q4 2019.
- Vanguard Group's portfolio value rose 8.7% quarter-over-quarter to $2.93T.
Based on Vanguard Group's 13F filing for Q4 2019, filed 14 Feb 2020.